Figure S1.
SARS-CoV-2 mouse models, related to Figure 1
(A) Neuroinvasive SARS-CoV-2 mouse model as a positive control for detection of virus in the brain. Confocal micrograph of coronal section of mouse brain, illustrating SARS-CoV-2 nucleocapsid protein (SARS-CoV-2-N) 7 days post-infection (7DPI) (SARS-CoV-2-N, magenta; DAPI, cyan). Scale bars, 1 mm.
(B) Mild respiratory COVID mouse model, detection of virus in the lung. Representative confocal micrographs of SARS-CoV-2 nucleocapsid protein (SARS-CoV-2-N, magenta; DAPI, cyan) in mouse lung 7 days post-infection, a time point at which the viral infection is largely cleared. Arrowheads highlight SARS-CoV-2-N nucleocapsid protein immunostaining (magenta). Scale bars, 100 μm.
(C) Mild respiratory COVID mouse model, hematoxylin and eosin (H&E) histology in mouse lung tissue at 7 days and 7 weeks post-mild respiratory SARS-CoV-2 infection (7WPI). Minimal interstitial infiltrates with patchy lymphoid aggregates were observed without evidence of alveolar damage. Scale bars, 200 μm.